One chart to understand IMOTIONTECH (01274) mid-year performance for 2026: Revenue grew 107.79% year-on-year.
Zhi Xing Technology (01274) announced its midterm results for 2026.
Recently, IMOTIONTECH (01274) announced its mid-year performance for 2026, reporting revenue of 761 million yuan, compared to 366 million yuan for the same period last year, marking a year-on-year increase of 107.79%. The gross profit was approximately 92.4 million yuan, a year-on-year increase of 441.20%, with the gross margin rising from 4.67% in the same period last year to 12.15%.
During the reporting period, the company generated approximately 664 million yuan in revenue from its combined driving assistance solutions and products, a year-on-year increase of 102.79%; revenue from the combined driving assistance domain controllers was approximately 547 million yuan, up 85.92%; revenue from smart front-view cameras was around 117 million yuan, a rise of 252.92%; and revenue from PCBA products and other auxiliary materials reached approximately 177 million yuan, also growing by 252.92%.
In the period, the company delivered over 289,000 sets of combined driving assistance solutions and products to customers, an increase of 149.14% year-on-year; as of June 30, 2026, the cumulative delivery has exceeded 1.123 million sets. With more customer vehicle models entering the mass production and delivery phase and the scale of project deliveries increasing, the company's revenue has grown rapidly, with economies of scale gradually becoming evident, leading to a significant improvement in gross margin.
Related Articles

PANGAEA CONNECT (01473): As of July 31, the total value of the sales contracts held by the group has further increased to approximately $1.15 billion.

Xingzheng Securities: September will be a crucial decisive window for technology, and high-quality tech assets are still expected to be the core driving force for market recovery.

Jiangsu Hengrui Pharmaceuticals (01276) experiences a shift in growth structure: acceleration of the second curve and global value release.
PANGAEA CONNECT (01473): As of July 31, the total value of the sales contracts held by the group has further increased to approximately $1.15 billion.

Xingzheng Securities: September will be a crucial decisive window for technology, and high-quality tech assets are still expected to be the core driving force for market recovery.

Jiangsu Hengrui Pharmaceuticals (01276) experiences a shift in growth structure: acceleration of the second curve and global value release.

RECOMMEND





